乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Lung Cancer

News, opinions and meeting coverage in oncology/hematology.

A photo of stacked creosote soaked timber next to a railroad track.

<乌鸦传媒>How Can Cancer Risk Be Cut in Communities Exposed to Toxins?

Group outlines plan to bring the latest testing and treatment to medically underserved minorities

A close-up photo of an eye affected by keratitis.

<乌鸦传媒>EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk

Findings don't tell us to stop these drugs, researcher says, but should guide clinical decisions

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA

News, features, and commentary about cancer-related issues

A photo of a mature man receiving radiotherapy.

<乌鸦传媒>Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC

Dose of 70 Gy in 15 fractions showed favorable balance between safety and efficacy in small trial

A photo of a surgeon performing an endoscopic aspiration biopsy

<乌鸦传媒>Cryobiopsy and Forceps Biopsy Go Head-to-Head for Diagnosing Lung Lesions

When added to needle aspiration, one method yielded better samples for molecular testing in NSCLC

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras

News, features, and commentary about cancer-related issues

An image of a senior man laying on a hospital bed with an intravenous line attached to his arm.

<乌鸦传媒>Futile Immunotherapy for Cancer Grows More Common

Occurs most often at non-academic and low-volume centers

A photo of a nurse administering chemotherapy to a male patient

<乌鸦传媒>Cancer Patients Face Frightening Delays in Treatment Approvals

"For them to take weeks -- up to months -- to provide an authorization is ridiculous"

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC

News, features, and commentary about cancer-related issues

A photo of a senior homeless man sitting on a park bench

<乌鸦传媒>Homelessness Tied to Worse Cancer Outcomes Among Veterans

However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trials

News, features, and commentary about cancer-related issues

A photo of the interior of a CT scanner.

<乌鸦传媒>Grappling With Our Deadliest Cancer

Here are essential steps to improve lung cancer screening

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish

News, features, and commentary about cancer-related issues

RSNA over a photo of McCormick Place South in Chicago, Illinois.

<乌鸦传媒>With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokers

Tool could identify nonsmokers most likely to benefit from low-dose CT screening

A photo of boxes of Tagrisso tablets over a computer rendering of non small cell lung cancer.

<乌鸦传媒>Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations

Researchers suggest the drug is a promising option for this rare subgroup

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care

News, features, and commentary about cancer-related issues

FDA APPROVED repotrectinib (Augtyro) over a computer rendering of a transparent body with lung cancer highlighted.

<乌鸦传媒>FDA OKs New Option for Advanced ROS1-Positive Lung Cancer

Drug achieved high response rates in TKI-naive and TKI-pretreated patients

CT scans of a patient with lung cancer.

<乌鸦传媒>Lung Cancer Survival High at 20 Years With Screen-Detected Tumors

After two decades, lung cancer-specific survival remained at 81% in I-ELCAP program

AANEM over a photo of JW Marriott Phoenix Desert Ridge Resort

<乌鸦传媒>Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S.

Findings suggest patients with SCLC are not screened for LEMS, despite their association

A multi-slice CT scan of a healthy patient鈥檚 chest.

<乌鸦传媒>ACS: Millions More Should Get Lung Cancer Screening

Notably, new recommendations say it doesn't matter when a person quit smoking

<乌鸦传媒>The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer

Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3

ESMO over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>New Options Challenge Standard Treatments in EGFR-Mutant NSCLC

Amivantamab-based regimens improved oncologic outcomes, but with more side effects

ESMO over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer

Adjuvant alectinib reduces disease-free survival hazard by 76%

ESMO over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers

Still some unanswered questions about benefit over other drug regimens, expert says

<乌鸦传媒>Targeting KRAS in NSCLC: Recent Progress and New Approaches

Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available

ESMO over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertions

Adding amivantamab to chemotherapy improved PFS, induced more rapid and durable responses

ESMO over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC

Two randomized studies demonstrate significantly improved PFS against standard regimens

ESMO over a photo of IFEMA Madrid in Spain.

<乌鸦传媒>Bi-Specific T-Cell Engager Active in Small-Cell Lung Cancer in Third Line and Beyond

Tarlatamab achieves 40% overall response rate at the dose selected for continued evaluation

FDA APPROVED pembrolizumab (Keytruda) + platinum-containing chemotherapy over a computer rendering of lung cancer.

<乌鸦传媒>Pembrolizumab Wins FDA Approval in Operable Lung Cancer

Checkpoint inhibitor demonstrated significant survival improvement in perioperative setting

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout?

News, features, and commentary about cancer-related issues

A photo of a woman undergoing a chest CT scan.

<乌鸦传媒>New Lung Cancer Cases Are Higher in Younger Women vs Men

And the higher incidence rates now extend to women ages 50 to 54 as well

FDA APPROVED encorafenib (Braftovi) over a computer rendering of lung cancer.

<乌鸦传媒>Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLC

Encorafenib plus binimetinib led to 75% ORR in untreated patients, 59% in treated patients

A photo of a male physician holding an endoscope in his green rubber gloved hands.

<乌鸦传媒>Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Results

Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Live

News, features, and commentary about cancer-related issues

FDA ADCOMM sotorasib (Lumakras) over a chest x-ray image of a patient with lung cancer.

<乌鸦传媒>Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panel

But聽agency doesn't plan to immediately push for KRAS inhibitor's withdrawal

ASTRO over a photo of San Diego Convention Center

<乌鸦传媒>Can ctDNA Guide Radiation Use in Oligometastatic NSCLC?

Detectable circulating tumor DNA before radiotherapy linked with worse survival

A photo of a bottle of Exkivity capsules over a computer rendering of lung cancer.

<乌鸦传媒>Drugmaker Plans to Pull Lung Cancer Therapy From the Market

Randomized trial of mobocertinib (Exkivity) failed to confirm聽benefit in rare tumor type

FDA ADCOMM sotorasib (Lumakras) over a chest x-ray image of a patient with lung cancer.

<乌鸦传媒>FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC

Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias"

3

鈥�